2008
Persistent and Relapsing Babesiosis in Immunocompromised Patients
Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, Furman RR, Neuhaus E, Skowron G, Gupta S, McCalla C, Pesanti EL, Young M, Heiman D, Hsue G, Gelfand JA, Wormser GP, Dickason J, Bia FJ, Hartman B, Telford SR, Christianson D, Dardick K, Coleman M, Girotto JE, Spielman A. Persistent and Relapsing Babesiosis in Immunocompromised Patients. Clinical Infectious Diseases 2008, 46: 370-376. PMID: 18181735, DOI: 10.1086/525852.Peer-Reviewed Original ResearchConceptsCase patientsAntibabesial treatmentClinical courseControl subjectsBlood smearsRetrospective case-control studyOptimal treatment regimenStandard antimicrobial therapyMalaria-like illnessBabesia microti infectionMost cases patientsCase-control studyCourse of therapyB-cell lymphomaAdministration of atovaquoneImmunologic statusStandard therapyAntimicrobial regimenSuch patientsTreatment regimenMicroti infectionAntimicrobial therapyPersistent infectionCell lymphomaAcute babesiosis
2007
Fellows’ Forum in Dialysis :edited by Mark A. Perazella: Nontuberculous Mycobacterial Peritonitis in Peritoneal Dialysis Patients
Rho M, Bia F, Brewster UC. Fellows’ Forum in Dialysis :edited by Mark A. Perazella: Nontuberculous Mycobacterial Peritonitis in Peritoneal Dialysis Patients. Seminars In Dialysis 2007, 20: 271-276. PMID: 17555495, DOI: 10.1111/j.1525-139x.2007.00289.x.Peer-Reviewed Case Reports and Technical NotesConceptsPeritoneal dialysis patientsMycobacterial peritonitisDialysis patientsSerious intra-abdominal complicationsMark A. PerazellaPrompt catheter removalIntra-abdominal complicationsCases of peritonitisPatient risk factorsManagement of PDCatheter removalPrompt diagnosisTherapeutic challengeRisk factorsAntimicrobial therapyUnique presentationAppropriate diagnosisMycobacterial infectionTreatment strategiesPeritonitisMycobacterium chelonaeInfectionDiagnosisMycobacterium gordonaePatients
2006
Bacillus megaterium delayed onset lamellar keratitis after LASIK.
Ramos-Esteban JC, Servat JJ, Tauber S, Bia F. Bacillus megaterium delayed onset lamellar keratitis after LASIK. Journal Of Refractive Surgery 2006, 22: 309-12. PMID: 16602323, DOI: 10.3928/1081-597x-20060301-20.Peer-Reviewed Case Reports and Technical NotesConceptsAntibiotic therapyClinical presentationMicrobial keratitisRight eye 2 weeksEye 2 weeksFinal visual acuityInitial clinical presentationOral antibiotic therapyAggressive antibiotic therapyCorrection of myopiaAntibiotic prophylaxisAffected eyeInfectious etiologySymptomatic reliefVisual acuityRight eyeUnusual presentationBacterial cultureMicrobiologic investigationsUneventful LASIKTherapeutic elevationRefractive surgeryLASIK flapStromal bedAseptic technique
2002
Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis
Finkelstein ES, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia FJ. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. American Journal Of Kidney Diseases 2002, 39: 1278-1286. PMID: 12046042, DOI: 10.1053/ajkd.2002.33403.Peer-Reviewed Original ResearchConceptsLong-term peritoneal dialysisEpisodes of infectionPeritoneal dialysisCatheter changeRepeat infectionsLong-term peritoneal dialysis (PD) therapyMultiple episodesEnd-stage renal diseaseCause of peritonitisPeritoneal dialysis therapyAntibiotic sensitivity patternCulture-positive peritonitisPattern of infectionSpearman correlation testPeritonitis episodesSubsequent peritonitisPeritoneal catheterRenal diseaseDialysis therapyCausative organismPeritonitisPatientsSensitivity patternSame organismInfection
1998
Human Granulocytic Ehrlichiosis During Pregnancy Treated Successfully with Rifampin
Buitrago MI, IJdo JW, Rinaudo P, Simon H, Copel J, Gadbaw J, Heimer R, Fikrig E, Bia FJ. Human Granulocytic Ehrlichiosis During Pregnancy Treated Successfully with Rifampin. Clinical Infectious Diseases 1998, 27: 213-215. PMID: 9675481, DOI: 10.1086/517678.Peer-Reviewed Case Reports and Technical Notes
1992
Comparison of enzyme-linked immunosorbent and indirect immunofluorescence assays for the detection of human T-cell lymphotropic virus type-I antibodies in sera from rural Haiti
Grant W, Bia F, Chacko T, Jean-Baptiste M, Griffith B. Comparison of enzyme-linked immunosorbent and indirect immunofluorescence assays for the detection of human T-cell lymphotropic virus type-I antibodies in sera from rural Haiti. Diagnostic Microbiology And Infectious Disease 1992, 15: 121-124. PMID: 1572136, DOI: 10.1016/0732-8893(92)90034-q.Peer-Reviewed Original ResearchConceptsWestern blotHuman T-cell lymphotropic virus type IHuman T-cell lymphotropic virusEnzyme immunoassayRural HaitiLymphotropic virus type IRural Haitian populationUninfected H9 cellsPrevalence of HTLVMT-2 cellsPositive samplesEnzyme-linked immunosorbentVirus type IAvailable enzyme immunoassayIndirect immunofluorescence assaysNeurologic diseaseLymphotropic virusH9 cellsHealthy individualsIndirect immunofluorescenceImmunofluorescence assaysSerum samplesHaitian populationSerumHTLV
1991
Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice.
Colson ER, Horwitz RI, Bia FJ, Viscoli CM. Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice. JAMA Internal Medicine 1991, 151: 709-13. PMID: 2012453, DOI: 10.1001/archinte.151.4.709.Peer-Reviewed Original ResearchConceptsZidovudine therapyDosage reductionAdverse outcomesHuman immunodeficiency virus type 1 (HIV-1) infectionClinical practiceHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Observational cohort studyHuman immunodeficiency virusTreatment of patientsType 1 infectionVirus type 1Zidovudine dosageCohort studyMost patientsImmunodeficiency virusBaseline cytopeniasTreatment outcomesPatterns of usePatientsTherapyType 1Dosage changesMonths
1986
Parasitic Infections of the Central Nervous System
Bia F, Barry M. Parasitic Infections of the Central Nervous System. Neurologic Clinics 1986, 4: 171-206. PMID: 3523201, DOI: 10.1016/s0733-8619(18)30994-0.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultAmebiasisAmebicidesAntimalarialsBrain AbscessCentral Nervous System DiseasesCysticercosisEchinococcosisEntamoebiasisEosinophiliaHumansMalariaMaleMeningitisMeningoencephalitisNeoplasmsParagonimiasisParasitic DiseasesSchistosomiasisStrongyloidiasisToxoplasmosisTrichinellosisConceptsParasitic infectionsOcular larva migransCentral nervous systemCerebral paragonimiasisDisseminated strongyloidiasisNeurologic complicationsHydatid diseaseCNS manifestationsClinical presentationCurrent therapiesLarva migransEosinophilic meningitisNervous systemInfectionDiseaseAdditional sectionsPresentationMeningitisToxoplasmosisComplicationsStrongyloidiasisParagonimiasisSchistosomiasisTherapyAmebiasis